Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The beneficial effects of reperfusion therapies have been limited by the amount of ischemic damage that occurs before reperfusion. To enable development of interventions to reduce cell injury, our research has focused on understanding mechanisms involved in cardiac cell death after ischemia/reperfusion (I/R) injury. In this context, our laboratory has been investigating the role of the receptor for advanced-glycation end products (RAGE) in myocardial I/R injury.

          Related collections

          Author and article information

          Journal
          Circulation
          Circulation
          Ovid Technologies (Wolters Kluwer Health)
          1524-4539
          0009-7322
          Mar 07 2006
          : 113
          : 9
          Affiliations
          [1 ] Division of Surgical Science, Department of Surgery, Columbia University Medical Center, New York, NY 10032, USA.
          Article
          CIRCULATIONAHA.105.575993
          10.1161/CIRCULATIONAHA.105.575993
          16505177
          38620a33-7d76-4c99-b61a-c25d7e047594
          History

          Comments

          Comment on this article